🔎 Trials Near Me

Home › Crohn's Disease › Rhode Island › Providence

Crohn's Disease clinical trials in Providence, RI

12 studies for Crohn's Disease are looking for participants at sites in and around Providence (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

RecruitingPhase 3
  • University Gastroenterology - Providence - West River Street ( Site 5057), Providence
Ages 16 to 80 · All sexes · Updated Oct 2, 2026 · NCT06430801

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

RecruitingPhase 2
  • University Gastroenterology - Providence - Staniford Street /ID# 280919, Providence
Ages 18 to 75 · All sexes · Updated Oct 2, 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

RecruitingPhase 4
  • University Gastroenterology, Providence
Ages 18 to 80 · All sexes · Updated Sep 30, 2026 · NCT06581328

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

RecruitingPhase 2/3
  • University Gastroenterology, Providence
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07196722

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

RecruitingPhase 2
  • University Gastroenterology Providence, Providence
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT06233461

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

RecruitingPhase 3
  • University Gastroenterology, Providence
Ages 18 to 70 · All sexes · Updated Sep 24, 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

RecruitingPhase 3
  • University Gastroenterology-Site Number: 8400103, Providence
Ages 16 to 80 · All sexes · Updated Sep 23, 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

RecruitingPhase 3
  • University Gastroenterology - GI Alliance-Site Number: 8400103, Providence
Ages 16 to 80 · All sexes · Updated Sep 23, 2026 · NCT07184944

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

RecruitingPhase 4
  • University Gastroenterology, Providence
Ages 18 to 70 · All sexes · Updated Sep 9, 2026 · NCT06045754

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Recruiting
  • Gastroenterology Associates, Providence
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT05230173

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

RecruitingPhase 4
  • Rhode Island Hospital, Providence
Ages 6 to 17 · All sexes · Updated May 27, 2026 · NCT05781152

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

RecruitingPhase 2
  • Mirador Therapeutics Selected Site, Providence
Ages 18 to 80 · All sexes · Updated Mar 12, 2026 · NCT07113522

About Crohn's Disease

Crohn's Disease can cause inflammation in any area from the mouth to the anus. Read about medicines, surgery or dietary management to treat symptoms.

More about Crohn's Disease on MedlinePlus

Crohn's Disease trials in other cities

Other studies in Providence

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.